In Vitro Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder Inhaler
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Aerosol Medicine and Pulmonary Drug Delivery"
DOI: 10.1089/jamp.2021.0061
Abstract: Background: Dry powder inhalers (DPIs) require patients to impart sufficient energy through inhalation to ensure adequate dose emission, medication deaggregation, and resultant particle sizes suitable for lung deposition. There is an ongoing debate regarding the… read more here.
Keywords: dose emission; dry powder; flow rates; delivery ... See more keywords